Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
43.42 EUR | +0.70% | -0.23% | +21.45% |
01/05 | Moody's Affirms NN Group's Rating on Leading Market Position | MT |
12/03 | Quotes from Dutch companies on the worsening business climate | RE |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Its low valuation, with P/E ratio at 6.79 and 6.35 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company is in debt and has limited leeway for investment
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.45% | 12.64B | A- | ||
+10.87% | 98.5B | B- | ||
+2.63% | 97.11B | B | ||
-9.85% | 85.02B | B+ | ||
+17.65% | 75.72B | D+ | ||
+8.49% | 30.79B | B | ||
+20.29% | 29.06B | B | ||
+6.64% | 27.68B | A | ||
+1.15% | 17.53B | C+ | ||
-12.31% | 14.85B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NN Stock
- Ratings NN Group N.V.